Trial Profile
A Randomised Placebo Controlled Trial of Rosuvastatin in Systemic Lupus Erythematosus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2019
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 22 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 18 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 May 2011 Planned End Date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.